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Background: Cuttlefish bone Xenograft, calcium phosphate (CaP)-based biomaterial graft, offers an alternative and has 
been accepted for osteoconductive and probable osteo-inductive attributes. This study aims to compare the bone healing 
potential between the bovine-derived (BHA) and cuttlefish bone-derived (CHA).
Materials and Methods: The study compared osteoblast cell proliferation of 27 New Zealand rabbits in 2.5 mm bone 
defect made in the femoral bone. The samples were divided into three groups, which were control, BHA and CHA group. 
The chemical and physical characteristics of BHA and CHA were determined for the content of hydroxyapatite by Fourier-
Transform Infrared Spectroscopy (FTIR) and X-Ray Diffraction (XRD), then tested by Scanning Electron Microscopy (SEM) 
to evaluate the porosity. In the end of the second week, histopathologic and immunohistochemistry examinations were 
performed to evaluate the amount of osteoblast and osteocalcin expression.  
Results: The FTIR, XRD and SEM analysis showed both BHA and CHA samples were hydroxyapatite according to Joint 
Committee on Powder Diffraction Standards (JCPDS). The CHA was significantly higher (297.22±19.772) compared to BHA 
(258.22±30.926) and control (131.67±34.213). Osteocalcin expression in CHA (7.82±2.230) compared to BHA (6.09±3.724) 
and control (4.07±3.606), was not significant (p>0.05).
Conclusion: CHA group has the highest osteoblast cell proliferation and osteocalcin expression, meaning has a good 
potential as future source of bone graft. 
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Introduction
Bone graft is a common technique in a bone defect to 
achieve secondary fracture healing where bone modelling 
and remodeling proceed.1 An ideal graft substitute should 
have bioresorbability, osteoconductive capacity, nontoxic, 
nonimmunogenic to the organism, easy to sterilize, and 
does not compromise mechanical stability.2,3 Currently, 
autograft is the gold standard for bone graft because of its 
osteoconduction, osteoinduction, and osteogenesis ability.4,5 
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It is, however, associated with a high morbidity and limited 
availability6,7, which pushes bone allografts to be used as 
natural substitute for bone defects1. Allograft also has a 
few disadvantages such as limited availability and risk of 
disease transmission, it presents some problems including 
rapid resorption, immunological rejection, infection, and 
technical difficulties in applying vascularized graft.5,6,8-11 Due 
to the limitations of autografts and allografts, xenografts are 
becoming a center of focus of studies to treat bone defects.12 
 Xenograft has been used frequently as bone graft 
substitutes with good results in recent years. Xenograft 
should contained hydroxyapatite biomaterial or calcium 
phosphate based that are similar to the human bone.5 Bovine 
bone shares the morphology, basic chemical composition, 
and crystallographic configuration of the mineral phase of 
the human bone, supporting new bone formation in contact 
area.7,8 It has been widely-used as a bone substitute because 
of its osteoconductive properties. It is also less susceptible 
to rejection or infection.13 In Indonesia, the most commonly 
used xenograft is bovine bone-derived.14 This material 
has been applied successfully in bone surgeries since they 
combine the morphology, basic chemical composition, 
and crystallographic configuration of the mineral phase of 
the bone.15-16 The use of bovine-derived xenograft (BHA)
would utilize cow bones that are considered organic waste. 
These bovine bones have recently become a serious issue in 
coastal areas of Indonesia, hence a large-scale use of these 
otherwise useless product could contribute to a decrease 
in pollution in those areas.17 However, the data for clinical 
efficacy and success rate of it is limited.18
 Another xenograft that is often used is a cuttlefish 
bone-derived xenograft (CHA). Cuttlefish bone is a natural 
biomaterial consisting mainly of calcium carbonate.3 
It has an internal lamella matrix that is formed by an 
interconnected parallel sheet which creates a highly porous 
structure similar to coral. Previous studies have suggested 
the use of this material as a scaffold due to this property.10 
It has an advantage compared to other alternatives as it 
contains aragonite that could convert into hydroxyapatite 
when processed hydrothermally. Because of its aragonite 
structure, it has been featured in several studies.16,19,20 It can 
also be obtained easily with a relatively cheap price globally. 
Due to its morphology and mineral structure, it can be 
shaped easily, hence making it compatibles with other types 
of bone structure with a high osteoinductive capacity.21,22
 An ideal biomaterial for a scaffold should have the 
following characteristics: 1) High interconnected-porosity 
which supports cell growth and transport of nutrition and 
metabolism products; 2) Mechanical capability suitable to 
the implantation site; 3) Chemically appropriate surface 
area for adhesion, proliferation, and differentiation of cells 
with minimal rejection from the surrounding tissue; and 
4) Biocompatibility and bioresorbability with a level of 
degradation and resorption time similar to a natural bone 
tissue.23 
 Histologically, the fracture healing process 
incorporating osteoblast activation from resting state or 
osteogenesis from osteoprogenitor in periosteum and 
marrow cavity in the form of fibrocartilage callus formation. 
By the end of the second week, soft callus has built into hard 
callus as woven bone. Osteoblast cells quantity are used 
to examine osteoprogenitor cells differentiation capacity 
which indicates a progress towards physiological fracture 
healing.11 Osteocalcin is the most abundant non-collagenous 
protein in mature human bone, expressed during osteoblast 
differentiation. It is one of the reliable markers of bone 
formation.12
 This study would like to compare the efficacy of bone 
fracture healing between BHA and CHA, by evaluating the 
amount of osteoblast cells (the nature of osteoconductive 
and osteo-inductive), and osteocalcin expression (osteoblast 
mature differentiation) in New Zealand white rabbit. 
Materials and methods
This study was a comparative experimental study. The 
samples were 27 New Zealand white male rabbits each aged 
six to nine months, and weighed 2500 to 3000 grams. All 
the samples were in good health without any presence of 
diseases or abnormality. 
 The materials used were consist of a BHA processed 
in the Tissue Bank Laboratory of  Dr. Soetomo General 
Hospital, Surabaya, and a CHA processed in hydrothermal 
reaction way in the Faculty of Science and Technology of 
Universitas Airlangga, Surabaya. The experimental unit 
used was freeze-dried hydroxyapatite xenograft pellet 
derived from each bone with gelatin (GEL) 10% as a binding 
material. To decrease the fragility of hydroxyapatite, surface 
modification by adding a binding material was done.24
 A chemical characteristics analysis was performed 
in Clinical Pharmacy Laboratory of Universitas 
Airlangga, Surabaya, using Fourier Transform Infrared 
Spectroscopy (FTIR)  to examine the Calcium (Ca) and 
Phosphorus (P) content, X-Ray Diffraction (XRD) to 
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examine the hydroxyapatite crystal content and Scanning 
Electron Microscope (SEM) to examine the porosity 
of each biomaterial. SEM showed pores visible with 
200x magnification, the average macrospore’s diameter 
of CHA (104.46 μm) and BHA (103.88 μm). The XRD 
analysis showed that the majority of samples consists of 
hydroxyapatite which fulfils the criteria of  Joint Committee 
on Powder Diffraction Standards (JCPDS). 
 The characteristics analysis using FTIR showed 
an organic component with a functional group which 
corresponds to the wave’s absorbance in a given frequency 
(cm-1). The FTIR spectrum of BHA showed a peak 
wavelength of 3396.76 whereas the spectrum of CHA 
showsed a peak wavelength of 3311.89 and 3572.29. These 
indicated that CHA and BHA is a suitable hydroxyapatite 
based on the chemical structure of Ca10(PO4)6(OH)2, and 
were confirmed to be hydroxyapatite based on the criteria of 
JCPDS. 
 The study was conducted at the Institute of Tropical 
Disease and Laboratory of Anatomical Pathology, Faculty of 
Veterinary, Universitas Airlangga, Surabaya, and the ethical 
clearance was issued by the ethical research committee of 
the Faculty of Veterinary, Universitas Airlangga, Surabaya. 
The samples were adapted to their cages for a week before 
the study begins. 
 The rabbits were anesthetized intramuscularly on 
the left quadriceps muscle using atropine sulphate and 
diazepam. Oxytetracycline was given as a prophylactic 
antibiotic. Bone defects were made in each of the rabbit’s 
distal metaphyseal region of the femur bilaterally with a 2.5 
mm drill bit. The injured rabbits were then divided into the 
BHA group, the CHA group and the control group. The bone 
defect in the treatment group were implanted with bone 
grafts respectively according to the group. Wound care was 
performed on the third day and every five day afterwards. 
 On the end of the second week, the sample animals 
were sacrificed by resecting the distal femur where all 
samples were performed. The specimens were soaked in 
buffer formalin solution and slow decalcified afterwards 
using an acidic hydrochloric solution. The solution was 
changed daily until the specimens softened. A sagittal 
dissection was made in the affected bone and processed into 
paraffin block.
 The  hematoxylin  and  Eosin  staining  (HE)  slides 
were further  examined  under  the  light  microscope, 
osteoblast cells were counted for 10 fields of 40x 
magnification. Immunohistochemistry examination was 
also prepared to evaluate  the  osteocalcin  expression.  The 
statistical analysis (Kruskal-Wallis and Mann-Whitney 
test) were performed using SPSS version 21 (SPSS Inc., 
Chicago, USA).
Results
The osteoblast cell count measured from the HE-staining 
slides with a 40x magnification (Figure 1) showed that 
the CHA group have the highest number (297.22±19.772) 
compared to the BHA group (258.22±30.926) and control 
group (131.67±34.213) (Table 1). According to the Kruskal-
Wallis test, the difference was statistically significant 
(p<0.001).
Table 1. Osteoblast cell count comparison between groups.
Kruskal-Wallis test, p<0.001.
Group n Mean SD p -value
Control 9 131.67 34.213
BHA 9 297.22 19.772
CHA 9 258.22 30.926
0.000*
Table 2. Osteocalcin expression comparison between groups.
Group n Mean SD p -value
Control 9 4.07 3.606
BHA 9 6.09 3.724
CHA 9 7.82 2.'230
0.114
Kruskal-Wallis test, p<0.001.
 Osteocalcin expression of the osteoblast cells as dark 
brown cytoplasmic staining were highly expressed by the 
CHA group calculated according to the modified Remmele 
method (Figure 2). The CHA group expresses the highest 
amount of osteocalcin (7.82±2.230) compared to the 
BHA group (6.09±3.724) and control group (4.07±3.606). 
However, the difference in osteocalcin expression was not 
significant (Table 2).
Discussion
 BHA is commonly used in orthopedic and dental 
procedure and it is commercially available. It exhibits 
similar properties to human bone when processed in the 
right temperature.13 It has 75-80% porosity and a large 
 78
Osteoblast Cell Proliferation and Osteocalcin Expression in CHA and BHAIrianto KA, et al.
Figure 1. The histologic picture of the control (A), BHA (B) and CHA (C) group. a: cortical bone; b: fibrosis; c: osteoblastic cells; 














interconnecting macropore and micropore system that 
facilitates angiogenesis and osteoblasts migration.14 
 The primary constituent of cuttlefish bone is calcium 
carbonate.16 The unique property of cuttlefish bone which 
has similar composition to human bones, is its high porosity 
which gives the cuttlefish its ability to float. Our study 
showed that CHA yields better osteoblast cell proliferation 
and higher osteocalcin production, therefore its structure 
is ideal as a scaffold. This is in accord with study reported 
by previous study which demonstrated that cuttlefish 
bone had excellent biocompatibility and osteogenic cell 
proliferation.17
 The CHA is an excellent scaffold for the attachment 
of osteoblast activated from the resting lined in bone 
trabeculae and pro-osteoblast derived from progenitor in 
marrow. Dogan and Okumus reported cuttlefish bone graft 
had faster fibrous union formation during the initial week 
after implantation and showed better angiogenesis in the 
first week and by the end of observation.6 The viability of 
the cells significantly increased in less than a week after 
implantation.18 
 The concept of osteoconduction of hydroxyapatite 
is well accepted while the ability for osteoinduction not to 
mention osteogenesis are open for discussion and further 
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Figure 2. The Immunohistochemistry staining osteocalcin expression in control group (A), BHA (B) and CHA (C) group. Red arrow: 
dark brown cytoplasmic staining; Yellow bar: 2.5 mm.
research. A study found that cuttlefish bone contains other 
trace metals beside calcium, including magnesium.20 
Magnesium ions are especially important in enhancing 
osteoblast cell attachment to orthopedic implant.21,22 
Furthermore, magnesium has the ability to promote the 
proliferation and differentiation of osteoblast.23 
 In contrast to the significant higher osteoblast 
proliferation in CHA group, the osteocalcin expression 
which indicates osteoblasts maturation was not significantly 
different, although still higher compared to others. The 
osteocalcin expression naturally showed in hard callus as 
it is maturing. Radiological evaluation of CHA in 3 weeks 
implantation showed 100% hard callus formation compare 
to 75% callus in BHA.6 
The result in this study suggested that CHA had compatible 
if not superior bone regenerative capability compared to 
BHA. Hopefully, this material could be applied clinically in 
the future as it offers a cheap, abundant alternative.24,25
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 The authors also realized the limitations of this study. 
The observation made in this study was one time only, at 
the end of second week after implantation. Further studies 
should incorporate continuous observation in each following 
week to better observe the degree of osteoblast maturation 
and osteocalcin expression in different stages of healing and 
proceed to evaluate the remodeling process which implicate 
the whole fracture healing. The authors also hope with this 
successful animal study, future clinical human application is 
achievable in near future.
Conclusion
Hydroxyapatite of the CHA yielded a higher osteoblast 
cell number compared to the BHA and control group. 
Furthermore, cuttlefish bone also presents a higher 
expression of osteocalcin which indicates mature osteoblast 
albeit insignificant statistically.
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